XtalPi Holdings Limited (HKG:2228)
Hong Kong · Delayed Price · Currency is HKD | Market Cap | 43.29B +82.8% |
| Revenue (ttm) | 746.09M +245.5% |
| Net Income | -215.64M |
| EPS | -0.07 |
| Shares Out | 4.30B |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 66,787,020 |
| Average Volume | 50,100,959 |
| Open | 9.76 |
| Previous Close | 9.73 |
| Day's Range | 9.71 - 10.17 |
| 52-Week Range | 3.85 - 15.12 |
| Beta | n/a |
| RSI | 37.92 |
| Earnings Date | Mar 27, 2026 |
About XtalPi Holdings
XtalPi Holdings Limited, an investment holding company, engages in the provision of robotics and drug discovery solutions in Mainland China, the United States, and internationally. The company offers XMolGen, an AI small molecule drug discovery smart computation platform; XtalFold, an antibody-antigen complex structure prediction platform which predicts the antibody-antigen complex structure and identifies key interaction sites; and Xtalgazer, a new generation of drug crystallization research and development platform which predict the physicoch... [Read more]
Financial Performance
In 2024, XtalPi Holdings's revenue was 266.43 million, an increase of 52.75% compared to the previous year's 174.42 million. Losses were -1.52 billion, -20.78% less than in 2023.
Financial numbers in CNY Financial StatementsNews
Chinese AI drug researcher XtalPi expects to turn first annual profit on 193% revenue jump
Chinese artificial intelligence-powered drug researcher XtalPi Holdings said it expects to turn its first annual profit on the back of strong revenue growth, according to a corporate filing. The Shenz...